secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0001104659-24-078937
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Warrant exercise raises $7M for Annovis Bio; 0.8M shares issued
---------------------------------------------------------------

- 0.8M November 2023 warrants exercised July 8-9, 2024 at $9.00 per share.
- Gross proceeds of $7.0M from the exercise.
- Approximately 0.8M shares of common stock issued.
- Warrants were part of a prior offering from Nov 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/0001104659-24-078937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/tm2419203d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-078937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer